Cargando…
Pitfalls of Cost-Effectiveness Analysis in Practice: A TRD Case Example in the United States with Esketamine Versus Oral Antidepressants
Autores principales: | Karkare, Swapna, Le, Hoa H., Sheehan, John J., Sliwa, Jennifer Kern, Zhang, Qiaoyi, Barber, Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391107/ https://www.ncbi.nlm.nih.gov/pubmed/32223604 http://dx.doi.org/10.18553/jmcp.2020.26.4.568 |
Ejemplares similares
-
Adverse Events and Measurement of Dissociation After the First Dose of Esketamine in Patients With TRD
por: Williamson, David, et al.
Publicado: (2022) -
Is (S)-norketamine an alternative antidepressant for esketamine?
por: Hashimoto, Kenji, et al.
Publicado: (2018) -
Pattern recognition in TRD/Tracker (TRD/T)
por: Gavrilenko, I
Publicado: (1992) -
ESKALE study, a French real-world study describing TRD patients with Esketamine nasal spray: final analysis
por: Samalin, L., et al.
Publicado: (2023) -
TRD Occupancies
por: Hawkings, R J, et al.
Publicado: (1993)